The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2

被引:133
|
作者
Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
机构
[1] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA
[2] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA
[3] Free Univ Berlin, Dept Biol, D-1000 Berlin, Germany
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
human coronavirus NL63; SARS coronavirus; angiotensin-converting enzyme 2; viral entry;
D O I
10.1016/j.virol.2007.04.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group It coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by beta-strands 4 and 5. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 50 条
  • [1] Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018
    Wang, Yanqun
    Li, Xin
    Liu, Wenkuan
    Gan, Mian
    Zhang, Lu
    Wang, Jin
    Zhang, Zhaoyong
    Zhu, Airu
    Li, Fang
    Sun, Jing
    Zhang, Guoxian
    Zhuang, Zhen
    Luo, Jiaying
    Chen, Dehui
    Qiu, Shuyan
    Zhang, Li
    Xu, Duo
    Mok, Chris Ka Pun
    Zhang, Fuchun
    Zhao, Jingxian
    Zhou, Rong
    Zhao, Jincun
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 246 - 255
  • [2] Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
    Satarker, Sairaj
    Nampoothiri, Madhavan
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (06) : 482 - 491
  • [3] Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
    Olaleye, Omonike A.
    Kaur, Manvir
    Onyenaka, Collins
    Adebusuyi, Tolulope
    HELIYON, 2021, 7 (03)
  • [4] Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
    Wu, Kailang
    Li, Weikai
    Peng, Guiqing
    Li, Fang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) : 19970 - 19974
  • [5] Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
    Zhao, Xuesen
    Guo, Fang
    Comunale, Mary Ann
    Mehta, Anand
    Sehgal, Mohit
    Jain, Pooja
    Cuconati, Andrea
    Lin, Hanxin
    Block, Timothy M.
    Chang, Jinhong
    Guo, Ju-Tao
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 206 - 216
  • [6] Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes
    Shao, Shiying
    Yang, Qin
    Pan, Ruping
    Yu, Xuefeng
    Chen, Yong
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
    Touyz, Rhian M.
    Li, Hongliang
    Delles, Christian
    CLINICAL SCIENCE, 2020, 134 (07) : 747 - 750
  • [8] Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options
    Khan, Suliman
    Siddique, Rabeea
    Shereen, Muhammad Adnan
    Ali, Ashaq
    Liu, Jianbo
    Bai, Qian
    Bashir, Nadia
    Xue, Mengzhou
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (05)
  • [9] Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
    Ortiz, Miguel E.
    Thurman, Andrew
    Pezzulo, Alejandro A.
    Leidinger, Mariah R.
    Klesney-Tait, Julia A.
    Karp, Philip H.
    Tan, Ping
    Wohlford-Lenane, Christine
    McCray, Paul B., Jr.
    Meyerholz, David K.
    EBIOMEDICINE, 2020, 60
  • [10] ACE-inhibitors, Angiotensin Receptor Blockers and Severe Acute Respiratory Syndrome Caused by Coronavirus
    Verdecchia, Paolo
    Reboldi, Gianpaolo
    Cavallini, Claudio
    Mazzotta, Giovanni
    Angeli, Fabio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (05) : 321 - 327